Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The needle used in the Wegovy weight loss pen is extremely fine, and the injection is shallow, targeting only the subcutaneous fat layer
The company says it is planning to initiate a Phase III development program with amycretin for adults with overweight or obesity during the first quarter of 2026
The release of those numbers comes just days after a watershed federal policy change: beginning July 1, 2026, eligible Medicare Part D beneficiaries can access GLP-1 medications approved for weight loss including Wegovy, oral Wegovy, Zepbound, and Foundayo for a flat $50 monthly copay through a new program called the Medicare GLP-1 Bridge
Still, it feels good to be the one choosing the risk especially after a long stretch of drug and alcohol dependency that burned my life to the ground
Semaglutide, initially developed by Novo Nordisk, received its first approval from the FDA under the name Ozempic on December 5, 2017
An opportunity to optimize overall health outcomes while achieving specific cosmetic goals
